CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 388 enrolled
Drug / intervention
Mometasone Furoate monohydrate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01118312
NCT01118312Phase 4Completed
CompareCT.gov

Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers

JHSPH Center for Clinical Trials·interventional·Posted May 6, 2010·Updated Nov 30, 2015

In Brief

A Phase 4 clinical trial evaluating Mometasone Furoate monohydrate and Placebo for Asthma and 2 related conditions. Completed, enrolled 388 participants across 19 sites.

Detailed Summary

The trial will study the effectiveness of nasal steroids for the treatment of chronic rhinitis and/or sinusitis on asthma control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Rhinitis, Sinusitis
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 6, 2010
Enrollment StartSep 1, 2010
Primary CompletionJun 1, 2014
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.2 years ago

Interventions

Mometasone Furoate monohydratedrug

Intranasal mometasone, 1 spray (age \< 12 yr) or 2 sprays (age \>= 12 yrs) each nostril once a day for 6 months

Placeboother

Intranasal placebo spray